Table 5.
Biochemical analysis of diabetic CLD patients with and without diabetic triopathy
| Triopathy | (–) | (+) | p value* |
|---|---|---|---|
| No. of patients | 28 | 12 | |
| FBS (mg/dl) | 127 (69–257) | 172 (110–266) | p<0.001 |
| HbA1c (%) | 6.3 (4.3–9.2) | 7.6 (5.7–10.8) | p<0.05 |
| Insulin (U/ml) | 22 (4.5–33.0) | 34 (9.3–69.1) | ns |
| HOMA-R | 4.1 (0.88–9.49) | 13.5 (3.1–32.2) | p<0.05 |
| TG (mg/dl) | 84 (33–205) | 80 (39–233) | ns |
| T-cho | 135 (70–221) | 151 (94–216) | ns |
| T-Bil (mg/dl) | 1.4 (0.4–4.9) | 1.0 (0.7–1.4) | ns |
| AST (IU/l) | 63 (21–154) | 51 (24–97) | ns |
| ALT (IU/l) | 54 (9–166) | 47 (17–83) | ns |
| Alb (g/dl) | 3.5 (1.8–4.7) | 3.4 (2.4–4.3) | ns |
| PT (%) | 72 (51–99) | 81 (58–100) | ns |
| Plt (×104/ml) | 9.7 (2.4–28.6) | 10.1 (3.9–18.8) | ns |
| CH | 12.8 (10.1–28.6) | 16 (8.1–18.8) | ns |
| LC | 7.1 (2.4–15) | 7.6 (3.9–14.6) | ns |
Values are expressed as median (range).
*
by Mann-Whitney’s U test or chi-square test. Abbreviations used are; CLD, chronic liver disease; FBS, fasting blood sugar; HbA1c, glycosylated hemoglobin; HOMA-R, homeostasis model assessment; TG, triglyceride; T-cho, total-cholesterol; T-Bil, total bilirubin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; Alb, serum albumin; PT, prothrombin time; Plt, platelet count; CH, chronic hepatitis; LC, liver cirrhosis; ns, not significant.